Carlson Capital L P Heron Therapeutics, Inc. Transaction History

Carlson Capital L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$16.93 - $26.22 $8.47 Million - $13.1 Million	-500,096 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$23.15 - $28.34 $11.2 Million - $13.7 Million	-483,464 Reduced 49.15%	500,096 $12.2 Million
Q4 2018 Feb 13, 2019	BUY	$22.03 - $32.01 $9.55 Million - $13.9 Million	433,310 Added 78.75%	983,560 $25.5 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $9.76 Million - $13.3 Million	325,250 Added 144.56%	550,250 $17.4 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $3.19 Million - $5.07 Million	-120,730 Reduced 34.92%	225,000 $8.74 Million
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $21.3 Million - $33.3 Million	-1,155,814 Reduced 76.98%	345,730 $9.54 Million
Q4 2017 Feb 14, 2018	SELL	$14.8 - $18.85 $6.98 Million - $8.89 Million	-471,391 Reduced 23.89%	1,501,544 $27.2 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $28.9 Million - $33.2 Million	1,972,935	1,972,935 $31.9 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital L P with notifications on news.